Biopsy-based algorithm found accurate for small renal masses
(HealthDay)—Compared with final pathology, biopsy of small renal masses (SRMs) can be accurately used in a treatment algorithm to direct management, according to research published in the February issue ...
Diseases, Conditions, Syndromes
Feb 09, 2013 |
not rated yet |
0
DAI provides potential imaging biomarker to indicate brain tumor response to RT
Diffusion abnormality index (DAI) shows promise as an imaging biomarker to measure brain tumor response to radiation therapy, according to research being presented at the 2013 Cancer Imaging and Radiation Therapy Symposium. ...
Cancer
Feb 08, 2013 |
not rated yet |
0
SUVmax provides valuable indicator of progression-free survival in stage I NSCLC patients
SUVmax (Maximum Standardized Uptake Value) may be a significant and clinically independent marker to indicate progression-free survival in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body ...
Cancer
Feb 08, 2013 |
not rated yet |
0
Study drug is first to help patients with recurrent low-grade ovarian cancer
Low-grade serous ovarian cancer is less common and aggressive than the high-grade variety, yet exceptionally difficult to treat when frontline therapy fails.
Cancer
Feb 08, 2013 |
not rated yet |
0
|
Reassuring evidence: Anticancer drug does not accelerate tumor growth after treatment ends
Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study ...
Cancer
Feb 07, 2013 |
not rated yet |
0
Compound stimulates tumor-fighting protein in cancer therapy
A compound that stimulates the production of a tumor-fighting protein may improve the usefulness of the protein in cancer therapy, according to a team of researchers.
Cancer
Feb 06, 2013 |
5 / 5 (5) |
0
|
Scientists identify molecular link between metabolism and breast cancer
(Medical Xpress)—A protein associated with conditions of metabolic imbalance, such as diabetes and obesity, may play a role in the development of aggressive forms of breast cancer, according to new findings by researchers ...
Cancer
Feb 06, 2013 |
5 / 5 (1) |
0
|
MicroRNA molecule may serve as biomarker, target for brain metastases in breast cancer patients
Researchers have identified two molecules that could potentially serve as biomarkers in predicting brain metastases in patients with breast cancer, according to data published in Cancer Research, a publication of the Americ ...
Cancer
Feb 05, 2013 |
not rated yet |
0
|
RNA promotes metastasis in lung cancer
The vast majority – approximately 80 percent – of our DNA does not code for proteins, yet it gets transcribed into RNA. These RNA molecules are called non-coding and fulfill multiple tasks in the cell. Alongside a well-studied ...
Cancer
Feb 05, 2013 |
not rated yet |
0
Researchers use new molecular inhibitors to successfully hit difficult cancer target
Early laboratory tests are the first to successfully use an experimental molecular therapy to block a hard-to-target part of a protein complex linked to several types of invasive cancer.
Cancer
Feb 05, 2013 |
5 / 5 (1) |
0
|
Epigenetic marker 5hmC opens door to studying its role in developmental disorders and disease
Nearly every cell in the human body carries a copy of the full human genome. So how is it that the cells that detect light in the human eye are so different from those of, say, the beating heart or the spleen?
Genetics
Feb 04, 2013 |
5 / 5 (1) |
0
|
Some cancer mutations slow tumor growth
A typical cancer cell has thousands of mutations scattered throughout its genome and hundreds of mutated genes. However, only a handful of those genes, known as drivers, are responsible for cancerous traits ...
Cancer
Feb 04, 2013 |
5 / 5 (1) |
0
|
Antibody hinders growth of Gleevec-resistant gastrointestinal tumors in lab tests
An antibody that binds to a molecule on the surface of a rare but deadly tumor of the gastrointestinal tract inhibits the growth of the cancer cells in mice, according to researchers at the Stanford University School of Medicine.
Cancer
Feb 04, 2013 |
4 / 5 (2) |
0
|
Researchers design mouse with more human-like immune response
Medical scientists at the University of Southern California (USC) have bred a first-of-its-kind mouse model that possesses an immune response system more like a human's. The discovery makes way for quicker ...
Immunology
Feb 04, 2013 |
5 / 5 (1) |
0
|
High-dose Vorinostat effective at treating relapsed lymphomas
Patients whose aggressive lymphomas have relapsed or failed to respond to the current front-line chemotherapy regimen now have an effective second line of attack against their disease. Reporting the results of a first-of-its-kind ...
Cancer
Feb 04, 2013 |
not rated yet |
0
